Evidence for 20 mg aspirin (ASA) as being optimal.
Sinzinger
H
H
Atherosclerosis Research Group (ASF) Vienna, Austria.
Virgolini
I
I
Eyb
R
R
Fitscha
P
P
Kaliman
J
J
D001095:Arachidonic Acids / Q000097:blood; D001241:Aspirin / Q000494:pharmacology* / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000502:physiology*; D011897:Random Allocation; D012016:Reference Values; D013927:Thrombosis / Q000517:prevention & control
D001095:Arachidonic Acids; D011453:Prostaglandins; D001241:Aspirin